HDAC I/IIb selective inhibitor Purinostat Mesylate combined with GLS1 inhibition effectively eliminates CML stem cells.
Qiu Q, Yang L, Feng Y, Zhu Z, Li N, Zheng L, Sun Y, Pan C, Qiu H, Cui X, He W, Wang F, Yi Y, Tang M, Yang Z, Yang Y, Li Z, Chen L, Hu Y.
Qiu Q, et al. Among authors: he w.
Bioact Mater. 2022 Sep 18;21:483-498. doi: 10.1016/j.bioactmat.2022.08.006. eCollection 2023 Mar.
Bioact Mater. 2022.
PMID: 36185739
Free PMC article.